Bethanechol
Parasympathomimetics
Urinary Bladder, Neurogenic
Urinary Retention

Bethanechol

Bethanechol is an FDA-approved medication used to manage postoperative and postpartum urinary retention, as well as overflow incontinence due to neurogenic bladder atony, and belongs to the parasympathomimetic drug class. This activity focuses on the clinical applications of bethanechol in managing nonobstructive urinary retention-related disorders. The indications, administration modalities, and contraindications will be covered. The program equips participants with essential knowledge to optimize patient outcomes by emphasizing the drug’s mechanism of action, adverse event profile, monitoring strategies, and clinical toxicology considerations. Furthermore, this activity explores critical aspects such as drug interactions and pharmacokinetics, enhancing healthcare professionals’ proficiency in tailoring therapeutic approaches for patients with conditions associated with nonobstructive urinary retention.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.